Glenmark Pharmaceuticals Ltd Share Price History : Returns Comparison, Growth Analysis

Home

Insights

History

Glenmark Pharmaceuticals Ltd Share Price History

₹ 1.0 Cr

Volume transacted

5.7 K

stocks traded

Last Updated time: 11 Sep 9.00 AM

Glenmark Pharmaceuticals Ltd

BSE

11 Sep, 2024

1727.751.1 (0.1%)

Prev Close

1726.6

Open Price

1725.05

Bid Price (QTY)

0.0 (0)

Offer Price (QTY)

0.0 (0)

Volume

5657

Today's High / Low

1742.8 / 1717.2

52 WK High / Low

1750.0 / 702.0

NSE

11 Sep, 2024

1725.65-2.2 (-0.1%)

Prev Close

1727.85

Open Price

1727.85

Bid Price (QTY)

1725.7 (43)

Offer Price (QTY)

0.0 (0)

Volume

1051257

Today's High / Low

1744.0 / 1715.2

52 WK High / Low

1750.5 / 722.1

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

To make informed investment decisions, regularly checking Glenmark Pharmaceuticals Ltd share price can be a beneficial practice. *All values are in Rupees.

Returns Comparison

10Y

Returns Comparison Table

Entity	1W	1M	3M	6M	1Y	3Y	5Y	10Y

Cipla Ltd	-1.5	2.7	6.4	8.2	30.6	71.3	245.3	182.7
Torrent Pharmaceuticals Ltd	-0.7	2.9	20.6	27.4	84.0	120.0	304.8	687.0
Sun Pharmaceuticals Industries Ltd	0.8	6.6	23.1	16.0	62.4	136.7	337.5	124.4
Glenmark Pharmaceuticals Ltd	2.4	15.0	45.0	80.8	113.1	232.9	349.1	126.0
Zydus Lifesciences Ltd	-1.4	-11.0	2.6	11.9	76.9	100.2	364.2	332.8
Divis Laboratories Ltd	6.7	11.1	21.5	50.9	45.7	6.9	236.2	533.6

Entity	1W
Cipla Ltd	-1.5
Torrent Pharmaceuticals Ltd	-0.7
Sun Pharmaceuticals Industries Ltd	0.8
Glenmark Pharmaceuticals Ltd	2.4
Zydus Lifesciences Ltd	-1.4
Divis Laboratories Ltd	6.7

Last updated time: 11 Sep 9.00 AM

Growth Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023	2024

Sales	9186	9103	9865	10641	10944	12305	11583	11813
Sales YoY Gr.	-	-0.9%	8.4%	7.9%	2.8%	12.4%	-5.9%	2.0%
Adj EPS	39.29	28.49	32.78	27.5	34.38	35.21	13.37	-50.8
YoY Gr.	-	-27.5%	15.1%	-16.1%	25.0%	2.4%	-62.0%	-480.0%
Adj Net Profit	1109	804	925	776	970	994	377	-1434
BVPS	159.21	182.99	198.65	215.14	250.37	322.03	335.75	278.11

Parameter	2017
Sales	9186
Sales YoY Gr.	-
Adj EPS	39.29
YoY Gr.	-
Adj Net Profit	1109
BVPS	159.21

Key Financial Parameters

Parameter	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

Return on Capital Emp. %	15.34	18.25	20.41	14.75	14.71	13.7	14.7	15.77	9.75	12.05
Op. Profit Mgn %	18.06	19.05	21.7	18.75	18.18	17.77	19.91	20.26	16.56	17.22
Net Profit Mgn %	3.9	9.71	12.07	8.83	8.3	7.29	8.86	9.42	5.96	-37.29
Debt to Equity %	1.48	1.44	1.07	0.97	0.84	0.8	0.75	0.55	0.46	0.34

Parameter	2015
Return on Capital Emp. %	15.34
Op. Profit Mgn %	18.06
Net Profit Mgn %	3.9
Debt to Equity %	1.48

Latest Shareholding

No data available

Promoters Holdings Over Time

No data available

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
Its branded generics business has a significant presence in markets across emerging economies including India.
The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.

Check out other companies share price history

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...

Divis Laboratories Ltd

Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...

Cipla Ltd

The Company is in the business of manufacturing, developing, and marketing wide ...

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...

Zydus Lifesciences Ltd

The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadoda...

Popular Search

Glenmark Pharmaceuticals Ltd dividend

Glenmark Pharmaceuticals Ltd pe ratio

Glenmark Pharmaceuticals Ltd market cap

Glenmark Pharmaceuticals Ltd option chain

Glenmark Pharmaceuticals Ltd financials

Sun Pharmaceuticals Industries Ltd share price history

Divis Laboratories Ltd share price history

Cipla Ltd share price history

Torrent Pharmaceuticals Ltd share price history

Zydus Lifesciences Ltd share price history

Dr Reddys Laboratories Ltd share price history

Lupin Ltd share price history

Mankind Pharma Ltd share price history

Aurobindo Pharma Ltd share price history

Alkem Laboratories Ltd share price history

FAQs for of Glenmark Pharmaceuticals Ltd

What factors influence the share price of Glenmark Pharmaceuticals Ltd over time?

The share price of Glenmark Pharmaceuticals Ltd is influenced by factors such as the company's financial performance, including earnings and revenue, as well as broader economic conditions and market trends. Furthermore, developments in the industry, regulatory changes, and geopolitical events can also impact the share price over time.

What are the key events that typically impact Glenmark Pharmaceuticals Ltd's share price history?

Key events that impact Glenmark Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.

How do stock splits affect Glenmark Pharmaceuticals Ltd's share price history?

Stock splits reduce the nominal price of Glenmark Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.

How do dividends impact the share price history of Glenmark Pharmaceuticals Ltd?

Dividends can influence Glenmark Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.

How do corporate announcements affect Glenmark Pharmaceuticals Ltd’s share price history?

Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Glenmark Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.

How can I use technical analysis to understand Glenmark Pharmaceuticals Ltd’s share price history?

To understand Glenmark Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*